Skip to Content
Search Menu

Nordic AML Insights - December Update

Explore Nordic AML research spanning single-cell and genomic analyses of leukemia heterogeneity, stem cell biology, and drug response, alongside population-based and clinical studies on survival outcomes, cytogenetics, germline predisposition, and transplantation trends.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Related

AML Insights – December Update: What’s New in the Field

/ Amanda Feldballe Bernholm / Jan Andreasen
AML

Top Abstract Spotlight: Menin Inhibitors are a Game Changer for the Treatment of Patients with Newly Diagnosed AML 

/ Jan Andreasen
AMLASH25

AML Insights – November Update: What’s New in the Field

/ Amanda Feldballe Bernholm / Jan Andreasen
AML

Nordic AML Insights – November Update

/ Amanda Feldballe Bernholm / Jan Andreasen
AML

Arsenic Trioxide-Induced Oral Manifestations: A Case of Vallate Papillae Swelling

/ Harisankar Anantharajan / Peter Bjerring / Luit Penninga / Carsten Sauer Mikkelsen
AML

AML Insights – June Update: What’s New in the Field

/ Jan Andreasen
AMLAML higlights

Nordic AML Insights – June Update: Research and EHA Congress

/ Jan Andreasen
AMLAML higlights
Carl Sandén

EHA 2025: Novel Immune Escape Pathway in AML Identified and Successfully Blocked

/ Carl Sandén
AMLEHA25 Play the Video 01:47
Justinas Daraskevicius

EHA 2025: Overcoming Venetoclax Resistance

/ Justinas Daraskevicius
AMLEHA25 Play the Video 02:20
Back to top